Cargando…
Pentraxin 3 Inhibits the Angiogenic Potential of Multiple Myeloma Cells
SIMPLE SUMMARY: Bone marrow (BM) angiogenesis represents a key aspect in the progression of multiple myeloma (MM) and is strictly linked to the balance between pro-angiogenic and anti-angiogenic players produced by both neoplastic and stromal components. It has been shown that Fibroblast Growth Fact...
Autores principales: | Ronca, Roberto, Taranto, Sara, Corsini, Michela, Tobia, Chiara, Ravelli, Cosetta, Rezzola, Sara, Belleri, Mirella, De Cillis, Floriana, Cattaneo, Annamaria, Presta, Marco, Giacomini, Arianna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125855/ https://www.ncbi.nlm.nih.gov/pubmed/34066669 http://dx.doi.org/10.3390/cancers13092255 |
Ejemplares similares
-
A long pentraxin-3-derived pentapeptide for the therapy of FGF8b-driven steroid hormone-regulated cancers
por: Giacomini, Arianna, et al.
Publicado: (2015) -
β-Galactosylceramidase Deficiency Causes Bone Marrow Vascular Defects in an Animal Model of Krabbe Disease
por: Belleri, Mirella, et al.
Publicado: (2019) -
Long Pentraxin-3 Follows and Modulates Bladder Cancer Progression
por: Matarazzo, Sara, et al.
Publicado: (2019) -
The natural FGF-trap long pentraxin 3 inhibits lymphangiogenesis and lymphatic dissemination
por: Turati, Marta, et al.
Publicado: (2022) -
FGF-trapping hampers cancer stem-like cells in uveal melanoma
por: Loda, Alessandra, et al.
Publicado: (2023)